| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02486796 Details | 2018-08-01 Interventional | 1/2 | 5 | Coenzyme Q10 Melatonin Ubiquinone Quality of Life | Operational barriers prevent critical specimen analyses from being performed. - | |||
| NCT02365233 Details | 2018-07-31 Interventional | 4 | 5 | Dipeptidyl-Pept… Insulin Insulin Glargin… Insulin, Globin… Pioglitazone Saxagliptin Sitagliptin Pho… Diabetes Mellit… Diabetes Mellit… Fatty Liver Non-alcoholic F… Nonalcoholic Fa… Type II Diabete… | IRB withheld the data due to inadequate supporting documentation Inadequate documentation and lack of funding resulted in no usable data. IRB withheld the data. | |||
| NCT00626574 Details | 2018-07-31 Interventional | 4 | 3 | Epoetin Alfa Hemorrhage Subarachnoid He… | This study is terminated as a result of data from a study that showed increased mortality in
stroke patients. In late October 2008, we received a letter from the sponsor requesting that we terminate any further work on this study. | |||
| NCT02914327 Details | 2018-07-30 Interventional | 1 | 0 | Ibrutinib Cancer | Lack of enrollment - | |||
| NCT02316847 Details | 2018-07-30 Interventional | 2 | 126 | Diazepam Epilepsy | - - | |||
| NCT01935947 NCT01846897 Details | 2018-07-27 Interventional | 2 | 17 | Azacitidine Camptothecin Docetaxel Entinostat Gemcitabine Histone Deacety… Irinotecan Pemetrexed Carcinoma, Non-… Lung Neoplasms Recurrent Non-S… Stage IIIA Non-… Stage IIIB Non-… Stage IV Non-Sm… | - Low recruitment lead to slow accrual. Not having enough patients on the trial and high disease progression lead to closing the study. | |||
| NCT03207542 Details | 2018-07-26 Interventional | 2 | 0 | Daratumumab Leukemia Leukemia, Lymph… Neoplasms Precursor Cell … Malignant Neopl… | PI request - | |||
| NCT02893826 Details | 2018-07-26 Interventional | 1 | 6 | Nimodipine Hemorrhage Subarachnoid He… Subarachnoid He… | Based on DMC recommendation to discontinue EG-01-1962-03 - | |||
| NCT02790632 Details | 2018-07-26 Interventional | 3 | - | Nimodipine Hemorrhage Subarachnoid He… Subarachnoid He… | DMC review concluded study has a low probability of meeting its primary endpoint - | |||
| NCT02737124 Details | 2018-07-26 Interventional | 3 | 0 | Acetaminophen Pain, Postopera… Post Operative … | Study is currently Lapsed - | |||
| NCT02621515 Details | 2018-07-26 Interventional | 2 | 7 | Nivolumab Brain Neoplasms Melanoma Neoplasm Metast… Brain Metastasi… | In the Netherlands we wanted to add pilimumab to nivolumab. This resulted in a very long METC
procedure which resulted in a to slow inclusion rate. - | |||
| NCT02386111 Details | 2018-07-26 Interventional | 1 | 17 | Sunitinib Carcinoma Carcinoma, Rena… Kidney Diseases Kidney Neoplasm… Neoplasms Neoplasms by Hi… Urogenital Neop… Urologic Diseas… Urologic Neopla… Clear-cell Meta… | Portfolio re-prioritization - | |||
| NCT02277132 Details | 2018-07-26 Interventional | 2/3 | 216 | Sildenafil Citr… Fetal Growth Re… Fetal Growth Re… | Results of interim analysis - | |||
| NCT02241551 Details | 2018-07-26 Interventional | 2 | 2 | Fluorouracil Gemcitabine Irinotecan Oxaliplatin Paclitaxel Pancreatic Neop… Borderline Rese… | Study was terminated with the IRB ended early as logistical concerns of the SBRT - | |||
| NCT01830270 Details | 2018-07-26 Interventional | 2 | [1 Refs] | 30 | Epirubicin Paclitaxel Esophageal Neop… Stomach Neoplas… Lower Oesophagu… Oesophageal Jun… | - - | ||
| NCT01654861 Details | 2018-07-26 Interventional | 1 | 3 | Ascorbic Acid Gemcitabine Adenocarcinoma Metastatic Aden… | recruiting or enrolling participants has halted prematurely and will not resume - | |||
| NCT01591473 Details | 2018-07-26 Interventional | 1/2 | [1 Refs] | 55 | Poly I-C poly(I).poly(c1… Influenza, Huma… | The CDC indicated nasal spray flu vaccine should not be used during 2016-2017 - | ||
| NCT01477853 2011-003600-20 Details | 2018-07-26 Interventional | 3 | 166 | Atorvastatin Glimepiride Metformin Sitagliptin Pho… Diabetes Mellit… Diabetes Mellit… Type 2 Diabetes… | The study was terminated early by the Sponsor for business reasons. The study was terminated early by the Sponsor for business reasons. Due to the small number of participants included in the FAS, the results for Phase A and for the overall study should be interpreted with caution. | |||
| NCT02095717 2013-002138-20 Details | 2018-07-24 Interventional | 2 | 50 | Curcumin Docetaxel Prostatic Neopl… Prostate Cancer… | The trial was stopped for futility in view of the results of the interim analysis - | |||
| NCT02066649 Details | 2018-07-24 Interventional | 3 | 0 | Carvedilol Hypertension Hypertension, P… Portal Hyperten… | We need to revise and redesign the study - |